PF 06687234: Clinical Trials

1 trial of PF 06687234, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 withdrawn. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Withdrawn 1

Follow PF 06687234: new trials by email Literature Review of PF 06687234 trials Research Report on PF 06687234

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Distribution of a Single IV Dose Of [124I]-Pf 06687234 and Pf 06687234 Assessed With PET-CT Imaging In Moderate To Severe Ulcerative Colitis and Crohn's Disease
PF 06687234, [124I]IB PF 06687234 - Inflammatory Bowel Disease
Phase 1WithdrawnPfizer2020-12-072020-11-03

Conditions studied

Inflammatory Bowel Diseases (1)

Sponsors

Pfizer (1)

Countries

United States (1)